CTT Pharmaceutical Holdings Inc (CTTH)

[tk2007]

Summary for CTT Pharmaceutical Holdings, Inc.
ticker: CTTH
429 Kent Street unit 112
Ottawa, ON K2P 2B4
Canada
613-241-9959
http://www.cttpharmaceuticals.com



SHARE STRUCTURE:
From https://www.otcmarkets.com/stock/CTTH/security
Authorized Shares: 300,000,000 as of 04/03/2018
Outstanding Shares: 39,359,222 as of 04/03/2018



COLLABRORATING/PARTNERING with AURORA CANNABIS ( trading symbol: $ACBFF, its market cap > $3B ):
Excerpts from PR on April 16, 2018 http://www.cttpharmaceuticals.com/aurora-cannabis-gains-exclusive-license-to-novel-patented-sub-lingual-wafer-technology-from-ctt-pharmaceutical/

Dr. Pankaj Modi, CEO of CTT Pharma, added,

“We are excited about the growth potential that our exclusive Canadian partnership with CanniMed and Aurora offers. Their large and rapidly growing patient base, both in Canada and around the world represent a significant distribution opportunity for our sub-lingual wafer technology, and with the establishment of CanniMed as the heart of Aurora’s Medical Cannabis Centre of Excellence, we anticipate that Aurora’s proven track record of execution will accelerate market development for our products.”

PATENTS:
The following list details all of CTT’s patents, their filing dates, and issuance dates:

Canadian Patents

1. Patent #2624110; Filed; 2008/03/27 Issued; 2010/11/09 - Dissolving Orally Administrable Wafer Formulation
2. Patent #2910206; Filed; 2015/10/23 Issued; 2016/12/13 - Novel Therapeutic Composition
3. Patent #2922959; Filed; 2016/03/03 Issued; 2018/01/02 - Orally Administrable Composition

US Patents

1. Patent #8623401; Filed; 2008/03/27 Issued;2014/01/07 - Wafer Formulation
2. Patent #9833461; Filed; 2015/10/23 Issued;2017/12/05 - Therapeutic Compositions Comprising Cannabidiol and Corticosteroids
3. Patent #2017/02523000A; Filed; 2017/04/07 Issued; Pending - Orally Administrable Composition

World Patents

1. World Patent (PCT) #2017/147691 In Process (151 Countries)
2. World Patent (PCT) #2017/147691A1 In Process (151 Countries)



TECHNOLOGY:

1. Drug Delivery: http://www.cttpharmaceuticals.com/drug-delivery/

2. Clinical Studies: http://www.cttpharmaceuticals.com/clinical-studies/




PRODUCTS:
1. MEDWAFE: http://www.cttpharmaceuticals.com/products/medwafe1/

2. CANNAWAFE: http://www.cttpharmaceuticals.com/products/cannawafe/

3. VETWAFE: http://www.cttpharmaceuticals.com/products/vetwafe-2/




NEWS:

May 22, 2018:
Aurora Expands Exclusive Access to CTT’s Product and Development Pipeline
https://www.cttpharmaceuticals.com/aurora-cannabis-makes-strategic-investment-in-ctt-pharmaceutical/


April 16, 2018:
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical
http://www.cttpharmaceuticals.com/aurora-cannabis-gains-exclusive-license-to-novel-patented-sub-lingual-wafer-technology-from-ctt-pharmaceutical/


April 3, 2018:
Legalizing medical cannabis might offer an alternative to narcotics to treat pain
http://www.cttpharmaceuticals.com/medical-marijuana-may-reduce-opioid-use-a-little/


March 15, 2018:
Aurora Acquires CanniMed and Commences Integration
http://www.cttpharmaceuticals.com/aurora-acquires-cannimed-and-commences-integration/


Feb 28, 2018:
Aurora Cannabis Announces Final Regulatory Approval for CanniMed Therapeutics Acquisition
http://www.cttpharmaceuticals.com/aurora-cannabis-announces-final-regulatory-approval-for-cannimed-therapeutics-acquisition/


Feb 21, 2018:
UPDATE–CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents
http://www.cttpharmaceuticals.com/update-ctt-pharmaceutical-holdings-inc-ctth-announces-canadian-patent-for-orally-administrable-nanonized-cannabinoids-opioids-and-other-pharmaceutical-agents/


Feb 6, 2018:
AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION
http://www.cttpharmaceuticals.com/aurora-cannabis-and-cannimed-therapeutics-file-offer-documents-for-previously-announced-friendly-acquisition/


Jan. 24, 2018:
Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction
http://www.cttpharmaceuticals.com/aurora-cannabis-and-cannimed-therapeutics-agree-to-terms-on-friendly-transaction/


Jan. 10, 2018:
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces U.S. Patent for Therapeutic Composition for Treating Psoriasis with Cannabidiol and Corticosteroids
http://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-inc-ctth-announces-u-s-patent-for-therapeutic-composition-for-treating-psoriasis-with-cannabidiol-and-corticosteroids/


For all CTT Pharmaceutical Holdings Inc. news, check out this link below:
http://www.cttpharmaceuticals.com/news/